Posted 1 year ago on Feb. 3, 2012, 9:57 a.m. EST by ZenDog
from South Burlington, VT
This content is user submitted and not an official statement
Main points of the article:
- “bypassed checks and balances of existing international IP norm-setting bodies [i.e. the World Trade Organization, the World Intellectual Property Organization, and the United Nations], without any meaningful input from national parliaments, policymakers, or their citizens,”
Copyright holders can bypass the legal system and request on their own that border agents seize property - even property destined to some third country. Under this bill generic drugs are treated the same as counterfit drugs; and Couts cites an interview in The Guardian with the lead ACTA EU negotiator, Kader Arif:
- “The problem with ACTA is that, by focusing on the fight against violation of intellectual property rights in general, it treats a generic drug just as a counterfeited drug, . . . This means the patent holder can stop the shipping of the drugs to a developing country, seize the cargo and even order the destruction of the drugs as a preventive measure.”
the bill creates incentive for stricter laws for copyright holders, without consideration of issues like public domain or fair use, and thus the fear that this will be used to curb freedom of expression.
Signed by the President as an executive agreement, which does not require Senate ratification - while the White House claims that if ACTA becomes international law, the US can ignore it. Some question the Constitutionality of this maneuver, and others say this sets a precedent that will allow other measures to avoid public scrutiny.
You will find more information on ACTA, and on TPPA [and other similar issues] at Digital Trends including action you can take.
Censorship has, in many respects, already begun